The National Institutes of Health is seeking comment from industry on a new artificial intelligence strategy for the agency. ...

Lamassu Biotech, a company with its “second headquarters” in Cleveland, has received a $2.7 million grant from the National ...

But new research published in JAMA Pediatrics found distinct patterns of long COVID symptoms in young children. Researchers ...

Sobi® (STO: SOBI) and Apellis Pharmaceuticals, Inc. today presented new data from the open-label period of the Phase 3 VALIANT ...

Separating Real Mitolyn Reviews From Growing Online Hype - A Data-Driven Safety Breakdown For 2025 Consumers Concerned About Quality And Side Effects PHILADELPHIA, NY / ACCESS Newswire / June 6, 2025 ...

In the VALIANT study, EMPAVELI demonstrated a statistically significant 68% proteinuria reduction versus placebo at Week 26, which was sustained at one year. Additionally, patients treated with ...

Sobi® (STO: SOBI) and Apellis Pharmaceuticals, Inc. today presented new data from the open-label period of the Phase 3 VALIANT study, investigating Aspaveli® ...

President Trump's 2026 budget proposes cutting NIH grants to universities, academic medical centers, and other institutions ...

The United States has the highest maternal mortality rate of any high-income country, a crisis perpetuated by the lack of ...

The HHS secretary said people should have access to experimental therapies including unregulated uses of stem cells. But some ...

Results from a new study help resolve the decade-long mystery of why many patients with the deadliest form of skin cancer do ...

An assortment of research across clinical and basic science fields was on full display at this year’s UB Resident and Fellow Research Day, which took place May 30 in the Jacobs School of Medicine and ...